【註1】
polycystic ovary syndrome (PCOS)
多囊卵巢綜合症(PCOS)
After the 12-week intervention, compared with the placebo, magnesium and zinc co-supplementation significantly decreased serum high-sensitivity C-reactive protein (hs-CRP)
干預12週後,與安慰劑相比,鎂和鋅共同補充顯著降低血清高敏C-反應蛋白(hs-CRP,和發炎有關)
Results of RT-PCR demonstrated that compared with the placebo, magnesium and zinc co-supplementation downregulated gene expression of interleukin-1 (IL-1) (P = 0.007) and tumor necrosis factor alpha (TNF-α) (P = 0.03) in PBMCs of subjects with PCOS.
RT-PCR結果顯示,與安慰劑相比,鎂和鋅共同補充下調PCOS受試者的白細胞介素-1(IL-1)和腫瘤壞死因子α(TNF-α)(和發炎有關)的基因表達
Overall, magnesium and zinc co-supplementation, compared with the placebo, for 12 weeks among PCOS women had beneficial effects
總體而言,與安慰劑相比,PCOS女性中的鎂和鋅共補充12週有正面的效益。
After the 12-week intervention, compared with the placebo, magnesium-zinc-calcium-vitamin D co-supplementation resulted in significant reductions in hirsutism
經過12週的干預,與安慰劑相比,鎂鋅鈣維生素D共同補充導致多毛症顯著減少